The global Hemodialysis Vascular Grafts Market size is expected to reach USD 276.5 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 4.1% during the forecast period. Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.
The global hemodialysis vascular graft market, by raw material, was dominated by PTFE grafts with a revenue share of 45.0% in 2018. The segment is anticipated to maintain its position throughout the forecast period. High product penetration, wide availability, and comparatively cheaper products are supplementing the dominance of the segment. Moreover, recent development of biological grafts for hemodialysis is expected to increase its adoption, owing to lower possibility of rejection and infection of these products.
North America dominated the market in 2018 and accounted for approximately 32.0% of the overall revenue. The U.S. is a key revenue contributor not only in the region but at the global marketplace as well. The growth of the market in the country can be attributed to growing number of renal impaired patients undergoing hemodialysis and surging demand for AVGs required to create superficial access for blood transfusion.
Developing economies such as China and India have lower availability of kidney donors as compared to developed economies. Thus patients opt for alternatives such as hemodialysis. Increase in number of hemodialysis procedures is expected to drive the market between 2018 and 2025. Asia Pacific is poised to exhibit a CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with CKD, growing awareness regarding safety of AVG, and rising healthcare expenditure.
Request a Sample Copy of the Global Hemodialysis Vascular Grafts Market Research Report @ https://www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market/request/rs1
Further Key Findings From the Report Suggest:
- North America dominated the market in 2017, owing to geightened awareness regarding treatment options available, increasing adoption of hemodialysis access grafts, and technological advancements in AVG
- Asia Pacific is anticipated to be the fastest growing regional hemodialysis vascular graft market with a CAGR of 6.6 % between 2018 and 2025
- Some of the key market players in this market are W.L. Gore & Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.; CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc.
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/5646/ibb
Grand View Research has segmented the global hemodialysis vascular graft market on the basis of raw material types, and region:
Hemodialysis Vascular Grafts Raw Material Outlook (Revenue, USD Million, 2014 – 2025)
- Polyester
- Polytetrafluoroethylene
- Polyurethane
- Biological Materials
Hemodialysis Vascular Grafts Regional Outlook (Revenue, USD Million, 2014 – 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
Browse Related Category @
Anastomosis Devices Market: Rising surgical procedures along with growing incidence of cardiovascular and gastrointestinal diseases are the key trends escalating market growth.
Coronary Stent Market: Increasing burden of cardiovascular diseases including coronary artery diseases are anticipated to boost the usage of coronary stents.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/hemodialysis-vascular-grafts-market